Cargando…
Factors influencing global antiretroviral procurement prices
BACKGROUND: Antiretroviral medicines (ARVs) are one of the most costly parts of HIV/AIDS treatment. Many countries are struggling to provide universal access to ARVs for all people living with HIV and AIDS. Although substantial price reductions of ARVs have occurred, especially between 2002 and 2008...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779508/ https://www.ncbi.nlm.nih.gov/pubmed/19922690 http://dx.doi.org/10.1186/1471-2458-9-S1-S6 |
_version_ | 1782174411583913984 |
---|---|
author | Wirtz, Veronika J Forsythe, Steven Valencia-Mendoza, Atanacio Bautista-Arredondo, Sergio |
author_facet | Wirtz, Veronika J Forsythe, Steven Valencia-Mendoza, Atanacio Bautista-Arredondo, Sergio |
author_sort | Wirtz, Veronika J |
collection | PubMed |
description | BACKGROUND: Antiretroviral medicines (ARVs) are one of the most costly parts of HIV/AIDS treatment. Many countries are struggling to provide universal access to ARVs for all people living with HIV and AIDS. Although substantial price reductions of ARVs have occurred, especially between 2002 and 2008, achieving sustainable access for the next several decades remains a major challenge for most low- and middle-income countries. The objectives of the present study were twofold: first, to analyze global ARV prices between 2005 and 2008 and associated factors, particularly procurement methods and key donor policies on ARV procurement efficiency; second, to discuss the options of procurement processes and policies that should be considered when implementing or reforming access to ARV programs. METHODS: An ARV-medicines price-analysis was carried out using the Global Price Reporting Mechanism from the World Health Organization. For a selection of 12 ARVs, global median prices and price variation were calculated. Linear regression models for each ARV were used to identify factors that were associated with lower procurement prices. Logistic regression models were used to identify the characteristics of those countries which procure below the highest and lowest direct manufactured costs. RESULTS: Three key factors appear to have an influence on a country's ARV prices: (a) whether the product is generic or not; (b) the socioeconomic status of the country; (c) whether the country is a member of the Clinton HIV/AIDS Initiative. Factors which did not influence procurement below the highest direct manufactured costs were HIV prevalence, procurement volume, whether the country belongs to the least developed countries or a focus country of the United States President's Emergency Plan For AIDS Relief. CONCLUSION: One of the principal mechanisms that can help to lower prices for ARV over the next several decades is increasing procurement efficiency. Benchmarking prices could be one useful tool to achieve this. |
format | Text |
id | pubmed-2779508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27795082009-11-20 Factors influencing global antiretroviral procurement prices Wirtz, Veronika J Forsythe, Steven Valencia-Mendoza, Atanacio Bautista-Arredondo, Sergio BMC Public Health Research BACKGROUND: Antiretroviral medicines (ARVs) are one of the most costly parts of HIV/AIDS treatment. Many countries are struggling to provide universal access to ARVs for all people living with HIV and AIDS. Although substantial price reductions of ARVs have occurred, especially between 2002 and 2008, achieving sustainable access for the next several decades remains a major challenge for most low- and middle-income countries. The objectives of the present study were twofold: first, to analyze global ARV prices between 2005 and 2008 and associated factors, particularly procurement methods and key donor policies on ARV procurement efficiency; second, to discuss the options of procurement processes and policies that should be considered when implementing or reforming access to ARV programs. METHODS: An ARV-medicines price-analysis was carried out using the Global Price Reporting Mechanism from the World Health Organization. For a selection of 12 ARVs, global median prices and price variation were calculated. Linear regression models for each ARV were used to identify factors that were associated with lower procurement prices. Logistic regression models were used to identify the characteristics of those countries which procure below the highest and lowest direct manufactured costs. RESULTS: Three key factors appear to have an influence on a country's ARV prices: (a) whether the product is generic or not; (b) the socioeconomic status of the country; (c) whether the country is a member of the Clinton HIV/AIDS Initiative. Factors which did not influence procurement below the highest direct manufactured costs were HIV prevalence, procurement volume, whether the country belongs to the least developed countries or a focus country of the United States President's Emergency Plan For AIDS Relief. CONCLUSION: One of the principal mechanisms that can help to lower prices for ARV over the next several decades is increasing procurement efficiency. Benchmarking prices could be one useful tool to achieve this. BioMed Central 2009-11-18 /pmc/articles/PMC2779508/ /pubmed/19922690 http://dx.doi.org/10.1186/1471-2458-9-S1-S6 Text en Copyright ©2009 Wirtz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Wirtz, Veronika J Forsythe, Steven Valencia-Mendoza, Atanacio Bautista-Arredondo, Sergio Factors influencing global antiretroviral procurement prices |
title | Factors influencing global antiretroviral procurement prices |
title_full | Factors influencing global antiretroviral procurement prices |
title_fullStr | Factors influencing global antiretroviral procurement prices |
title_full_unstemmed | Factors influencing global antiretroviral procurement prices |
title_short | Factors influencing global antiretroviral procurement prices |
title_sort | factors influencing global antiretroviral procurement prices |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779508/ https://www.ncbi.nlm.nih.gov/pubmed/19922690 http://dx.doi.org/10.1186/1471-2458-9-S1-S6 |
work_keys_str_mv | AT wirtzveronikaj factorsinfluencingglobalantiretroviralprocurementprices AT forsythesteven factorsinfluencingglobalantiretroviralprocurementprices AT valenciamendozaatanacio factorsinfluencingglobalantiretroviralprocurementprices AT bautistaarredondosergio factorsinfluencingglobalantiretroviralprocurementprices |